Cambray G J, Murphy G, Reynolds J J
Rheumatol Int. 1981;1(2):69-72. doi: 10.1007/BF00541156.
Using a rabbit model arthritis we have investigated the ability of dexamethasone to alter the production of collagenase and the specific metallo-proteinase inhibitor TIMP by explants of synovium and cartilage in vitro. The patterns of collagenase and TIMP production by untreated explants from arthritic joint tissues in culture were similar to those described previously [1, 2]. Dexamethasone dramatically altered the patterns of production of collagenase and TIMP. At a dose of 10 nM, or above, the patterns of production by treated synovium resembled those of normal rabbit synovium: collagenase production was suppressed and TIMP increased compared with untreated arthritic synovium. The levels of latent collagenase in cartilage also fell with increasing doses of dexamethasone and TIMP levels were higher, although normal levels were not reached. These experiments have been conducted as a prelude to testing the effects of various anti-rheumatic drugs in vivo, and attempting to correlate changes in clinical parameters with the subsequent production of collagenase and TIMP in vitro. The data are discussed in relation to the therapeutic use of corticosteroids and to their mode of action on joint tissues.
利用兔关节炎模型,我们研究了地塞米松在体外改变滑膜和软骨外植体中胶原酶及特异性金属蛋白酶抑制剂(TIMP)产生的能力。来自关节炎关节组织的未经处理的外植体在培养中产生胶原酶和TIMP的模式与先前描述的相似[1,2]。地塞米松显著改变了胶原酶和TIMP的产生模式。在10 nM或更高剂量时,经处理的滑膜的产生模式类似于正常兔滑膜:与未经处理的关节炎滑膜相比,胶原酶产生受到抑制,TIMP增加。随着地塞米松剂量增加,软骨中潜在胶原酶水平也下降,TIMP水平升高,尽管未达到正常水平。这些实验是作为测试各种抗风湿药物体内作用的前奏进行的,并试图将临床参数的变化与随后体外胶原酶和TIMP的产生相关联。本文就皮质类固醇的治疗用途及其对关节组织的作用方式对数据进行了讨论。